Eiger BioPharmaceuticals, Inc. (EIGR) Financial Statements (2024 and earlier)

Company Profile

Business Address 2155 PARK BOULEVARD
PALO ALTO, CA 94306
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:98,90088,800128,90095,000100,35341,779
Cash and cash equivalents25,79822,22128,86439,37361,26232,035
Short-term investments73,15066,59499,97655,62139,0919,744
Other undisclosed cash, cash equivalents, and short-term investments(48)(15)606  
Receivables1,7492,576    
Inventory, net of allowances, customer advances and progress billings2,8532,612    
Inventory2,8532,612    
Prepaid expense586631448   
Deposits current assets4,542     
Other undisclosed current assets8,9058,7458,4585,3841,492712
Total current assets:117,535103,364137,806100,384101,84542,491
Noncurrent Assets
Operating lease, right-of-use asset5616531,1761,654
Property, plant and equipment69661370959016779
Long-term investments and receivables  17,262    
Long-term investments  17,262    
Other noncurrent assets1,3474,5103,9032,511436312
Total noncurrent assets:2,60423,0385,7884,755603391
TOTAL ASSETS:120,139126,402143,594105,139102,44842,882
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities24,63021,46416,04516,41510,0245,267
Accounts payable8,9757,7654,6406,4145,8303,183
Accrued liabilities15,65513,69911,40510,0014,1942,084
Debt  7,809 534 2,002
Other undisclosed current liabilities491628582   
Total current liabilities:25,12129,90116,62716,94910,0247,269
Noncurrent Liabilities
Long-term debt and lease obligation39,62524,10231,93231,71025,62013,091
Long-term debt, excluding current maturities39,62523,98631,19430,39025,62013,091
Liabilities, other than long-term debt 83   212 
Other liabilities     212 
Operating lease, liability 831167381,320
Other undisclosed noncurrent liabilities  (116)(738)   
Total noncurrent liabilities:39,70824,10231,93231,71025,83213,091
Total liabilities:64,82954,00348,55948,65935,85620,360
Equity
Equity, attributable to parent55,31072,39995,03556,48066,59222,522
Common stock443534241911
Additional paid in capital492,759412,930401,509297,863237,795141,320
Accumulated other comprehensive income (loss)(300)(149)(8)42(25)(3)
Accumulated deficit(437,193)(340,417)(306,500)(241,449)(171,197)(118,806)
Total equity:55,31072,39995,03556,48066,59222,522
TOTAL LIABILITIES AND EQUITY:120,139126,402143,594105,139102,44842,882

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues13,48412,142    
Cost of revenue(1,837)(745)    
Cost of goods and services sold(1,043)     
Gross profit:11,64711,397    
Operating expenses(104,387)(88,336)(62,149)(68,904)(51,047)(41,520)
Other undisclosed operating income      
Operating loss:(92,740)(76,939)(62,149)(68,904)(51,047)(41,520)
Nonoperating income11946,6456922,058985596
Investment income, nonoperating1,0821587042,073997410
Other nonoperating income (expense)(963)46,487(12)(15)(12)186
Interest and debt expense(4,132)(3,559)(3,594)(3,406)(2,329)(1,524)
Loss from continuing operations before income taxes:(96,753)(33,853)(65,051)(70,252)(52,391)(42,448)
Income tax expense(23)(64)    
Loss from continuing operations:(96,776)(33,917)(65,051)(70,252)(52,391)(42,448)
Loss before gain (loss) on sale of properties:(33,917)(65,051)(70,252)(52,391)(42,448)
Net loss available to common stockholders, diluted:(96,776)(33,917)(65,051)(70,252)(52,391)(42,448)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(96,776)(33,917)(65,051)(70,252)(52,391)(42,448)
Comprehensive loss:(96,776)(33,917)(65,051)(70,252)(52,391)(42,448)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(151)(141)(50)67(22)12
Comprehensive loss, net of tax, attributable to parent:(96,927)(34,058)(65,101)(70,185)(52,413)(42,436)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: